Wei Cao

Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD.

Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.

Part of Gracell Biotechnologies, Inc., Gracell Biotechnologies (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China. The Chinese company discovers and develops cellular therapeutics for patients suffering from cancer. The private company was founded in 2017 by Wei Cao, who has been the CEO since 2017.

Part of Gracell Biotechnologies, Inc., Suzhou Gracell Biotechnologies Co., Ltd. is a private company that manufactures cancer cellular medicines. The company is based in Suzhou, China. The CEO of the Chinese company is Wei Cao.